| ISIN | CH0517863152 |
|---|---|
| Valor Number | 51786315 |
| Bloomberg Global ID | |
| Fund Name | Swisscanto (CH) Index Equity Fund United Kingdom MT GBP |
| Fund Provider |
Swisscanto Fondsleitung AG
Zurich E-Mail: fonds@swisscanto.ch |
| Fund Provider | Swisscanto Fondsleitung AG |
| Representative in Switzerland | |
| Distributor(s) | Schweizerische Kantonalbanken |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Switzerland |
| Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
| Redemption Condition | The fund charges a transaction fee (contribution towards covering expenses incurred in the sale of assets) |
| Investment Strategy *** | Die Anlagen dieses Teilvermögens erfolgen in Anlehnung an den MSCI® United Kingdom Index, welcher von der MORGAN STANLEY CAPITAL INTERNATIONAL INC. (MSCI) fest-gelegt und berechnet wird und darauf ausgelegt ist, die Performance der Mid- und Large Cap Segmente des Marktes des Vereinigten Königreiches (Grossbritannien und Nordirland) zu messen. |
| Peculiarities |
| Current Price * | 155.20 GBP | 15.12.2025 |
|---|---|---|
| Previous Price * | 153.57 GBP | 12.12.2025 |
| 52 Week High * | 157.57 GBP | 12.11.2025 |
| 52 Week Low * | 119.74 GBP | 09.04.2025 |
| NAV * | 155.20 GBP | 15.12.2025 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 97,635,041 | |
| Unit/Share Assets *** | 10,726,681 | |
| Trading Information SIX | ||
| YTD Performance | +23.34% |
31.12.2024 - 15.12.2025
31.12.2024 15.12.2025 |
|---|---|---|
| YTD Performance (in CHF) | +15.61% |
31.12.2024 - 15.12.2025
31.12.2024 15.12.2025 |
| 1 month | +0.72% |
17.11.2025 - 15.12.2025
17.11.2025 15.12.2025 |
| 3 months | +5.72% |
15.09.2025 - 15.12.2025
15.09.2025 15.12.2025 |
| 6 months | +11.69% |
16.06.2025 - 15.12.2025
16.06.2025 15.12.2025 |
| 1 year | +22.19% |
16.12.2024 - 15.12.2025
16.12.2024 15.12.2025 |
| 2 years | +37.92% |
15.12.2023 - 15.12.2025
15.12.2023 15.12.2025 |
| 3 years | +45.88% |
15.12.2022 - 15.12.2025
15.12.2022 15.12.2025 |
| 5 years | +84.51% |
15.12.2020 - 15.12.2025
15.12.2020 15.12.2025 |
| Equity Participation Rate in % | 98.31 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| AstraZeneca PLC | 9.61% | |
|---|---|---|
| HSBC Holdings PLC | 8.18% | |
| Shell PLC | 7.16% | |
| Unilever PLC | 4.94% | |
| British American Tobacco PLC | 4.28% | |
| Rolls-Royce Holdings PLC | 4.00% | |
| GSK PLC | 3.24% | |
| BP PLC | 3.17% | |
| Rio Tinto PLC Ordinary Shares | 2.71% | |
| Barclays PLC | 2.67% | |
| Last data update | 30.11.2025 | |
| TER | 0.00% |
|---|---|
| TER date | 30.09.2024 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | |
| Ongoing Charges *** | 0.00% |
|
SRRI ***
|
|
| SRRI date *** | 30.11.2025 |